zanamivir has been researched along with mannitol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Mei, X; Ren, Y; Yang, Y; Yang, Z | 1 |
| Cai, X; Mei, X; Xie, X; Yang, Y; Yang, Z; Yu, F; Zhang, T | 1 |
3 other study(ies) available for zanamivir and mannitol
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Effects of formulation and operating variables on zanamivir dry powder inhalation characteristics and aerosolization performance.
Topics: Administration, Inhalation; Aerosols; Chemistry, Pharmaceutical; Excipients; Leucine; Mannitol; Particle Size; Powders; Zanamivir | 2014 |
Preparation, characterization and pulmonary pharmacokinetics of a new inhalable zanamivir dry powder.
Topics: Administration, Inhalation; Animals; Chemistry, Pharmaceutical; Dry Powder Inhalers; Lung; Mannitol; Nanoparticles; Optical Imaging; Rats; X-Ray Diffraction; Zanamivir | 2016 |